Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Esnouf

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Pathophysiology of Haemostasis and Thrombosis|July 11, 2003
A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapyCraig M Jackson, M Peter Esnouf, Tomas L Lindahl
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2009
FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy menHelen A Ireland, Jackie A Cooper, Fotios Drenos, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Pathophysiology of Haemostasis and Thrombosis|July 11, 2003
A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapyCraig M Jackson, M Peter Esnouf, Tomas L Lindahl
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2009
FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy menHelen A Ireland, Jackie A Cooper, Fotios Drenos, et al.
Pageof 1